Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
申请人:Pharmacopeia, LLC
公开号:US08288371B2
公开(公告)日:2012-10-16
Compounds of the formula
are disclosed. The compounds are CCR1 antagonists which are useful for the treatment and prevention of inflammatory and autoimmune diseases. Other embodiments are also disclosed.
本发明揭示了一种公式为的化合物。这些化合物是CCR1拮抗剂,可用于治疗和预防炎症和自身免疫性疾病。本发明还揭示了其他实施方案。